EZACTRIS

79115742 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed March 26, 2012
Serial No. 79115742
Examining Attorney LINDA M LAVACHE
Interlocutory Attorney ANDREW P BAXLEY
Class Pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in or affecting the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, epilepsy, sclerosis, porphyries, Huntington's disease, insomnia, Parkinson disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes; 006; 018; 044; 046; 051; 052
EZACTRIS
Status U.S. application abandoned because International Registration restricted, renounced, or expired, in whole or in part. No transformation or petition to revive is allowed.
Opposition 91209837
Eli Lilly and Company v. H. Lundbeck A/S
  • H. Lundbeck A/S;
  • Eli Lilly and Company;
Opposition 79115742
Eli Lilly and Company v. H. Lundbeck A/S
  • H. Lundbeck A/S;
  • Eli Lilly and Company;
Last Updated: 1 year, 8 months ago
Filing Date # Docket Text
10/25/2022
10/25/2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
10/24/2022DEATH OF INTERNATIONAL REGISTRATION
10/20/2022
10/10/2014FINAL DECISION TRANSACTION PROCESSED BY IB
10/9/2014
9/25/2014
9/25/2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
9/25/2014FINAL DISPOSITION NOTICE SENT TO IB
9/25/2013
9/25/2013OPPOSITION SUSTAINED NO. 999999
9/25/2013OPPOSITION TERMINATED NO. 999999
9/25/2013ABANDONMENT - AFTER INTER PARTES DECISION
9/25/2013ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
4/16/2013REFUSAL PROCESSED BY IB
4/11/2013
3/20/2013OPPOSITION INSTITUTED NO. 999999
3/19/2013
3/19/2013OPPOSITION NOTICE (IB REFUSAL) CREATED
3/19/2013OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
3/18/2013TTAB Proceeding Filed: Eli Lilly and Company v. H. Lundbeck A/S, 91209837
2/8/2013NOTIFICATION PROCESSED BY IB
1/31/2013
12/18/2012EXTENSION OF TIME TO OPPOSE RECEIVED
12/14/2012TTAB Proceeding Filed: Eli Lilly and Company v. H. Lundbeck A/S, 79115742
11/27/2012
11/27/2012PUBLISHED FOR OPPOSITION
11/27/2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/7/2012
11/7/2012
11/7/2012
11/7/2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/7/2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/7/2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/23/2012
10/22/2012LAW OFFICE PUBLICATION REVIEW COMPLETED
10/19/2012ASSIGNED TO LIE
10/6/2012
10/6/2012
10/5/2012TEAS/EMAIL CORRESPONDENCE ENTERED
10/5/2012APPROVED FOR PUB - PRINCIPAL REGISTER
10/4/2012
10/4/2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/4/2012CORRESPONDENCE RECEIVED IN LAW OFFICE
9/15/2012REFUSAL PROCESSED BY IB
9/13/2012
8/27/2012
8/27/2012REFUSAL PROCESSED BY MPU
8/27/2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
8/25/2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
8/24/2012
8/24/2012
8/24/2012
8/24/2012NON-FINAL ACTION WRITTEN
8/21/2012
8/21/2012APPLICATION FILING RECEIPT MAILED
8/17/2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
8/17/2012ASSIGNED TO EXAMINER
8/16/2012
8/16/2012
8/16/2012SN ASSIGNED FOR SECT 66A APPL FROM IB
8/16/2012LIMITATION FROM ORIGINAL APPLICATION ENTERED